Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Apr;44(4):317–320. doi: 10.1136/jcp.44.4.317

Congenital mesoblastic nephroma: possible prognostic and management value of assessing DNA content.

J C Barrantes 1, C Toyn 1, K R Muir 1, S E Parkes 1, F Raafat 1, A H Cameron 1, H B Marsden 1, J R Mann 1
PMCID: PMC496908  PMID: 1851500

Abstract

The case records and pathology of all children with kidney tumours treated in the West Midlands Health Authority Region (WMHAR) from 1957 to 1986 were reviewed. The histology was reviewed by a panel of three paediatric pathologists. Thirteen (6%) out of 211 cases were considered to have congenital mesoblastic nephroma (CMN). Nine were of the conventional type, three of the atypical cellular type, and one mixed. DNA ploidy was investigated and showed two of the tumours to be aneuploid and nine diploid (tissue was not available in the two other cases). The two aneuploid tumours were of atypical cellular and mixed histology, respectively; the diploid tumours were of the conventional type in eight cases and atypical cellular in one. The atypical cellular type has been reported to behave more aggressively, but the benefit of additional treatment after surgery to prevent recurrence remains unclear. Measurement of DNA content by flow cytometry, together with histological subclassification, may be useful in selecting patients who will benefit from further treatment after surgery.

Full text

PDF
317

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckwith J. B. Mesenchymal renal neoplasms of infancy revisited. J Pediatr Surg. 1974 Dec;9(6):803–805. doi: 10.1016/s0022-3468(74)80210-1. [DOI] [PubMed] [Google Scholar]
  2. Bolande R. P. Congenital mesoblastic nephroma of infancy. Perspect Pediatr Pathol. 1973;1:227–250. [PubMed] [Google Scholar]
  3. Chan H. S., Cheng M. Y., Mancer K., Payton D., Weitzman S. S., Kotecha P., Daneman A. Congenital mesoblastic nephroma: a clinicoradiologic study of 17 cases representing the pathologic spectrum of the disease. J Pediatr. 1987 Jul;111(1):64–70. doi: 10.1016/s0022-3476(87)80343-8. [DOI] [PubMed] [Google Scholar]
  4. D'Angio G. J., Evans A., Breslow N., Beckwith B., Bishop H., Farewell V., Goodwin W., Leape L., Palmer N., Sinks L. The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study. Cancer. 1981 May 1;47(9):2302–2311. doi: 10.1002/1097-0142(19810501)47:9<2302::aid-cncr2820470933>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  5. Douglass E. C., Look A. T., Webber B., Parham D., Wilimas J. A., Green A. A., Roberson P. K. Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms' tumor. J Clin Oncol. 1986 Jun;4(6):975–981. doi: 10.1200/JCO.1986.4.6.975. [DOI] [PubMed] [Google Scholar]
  6. Farewell V. T., D'Angio G. J., Breslow N., Norkool P. Retrospective validation of a new staging system for Wilms' tumor. Cancer Clin Trials. 1981;4(2):167–171. [PubMed] [Google Scholar]
  7. Frierson H. F., Jr Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin-embedded specimens. Hum Pathol. 1988 Mar;19(3):290–294. doi: 10.1016/s0046-8177(88)80521-5. [DOI] [PubMed] [Google Scholar]
  8. Fu Y., Kay S. Congenital mesoblastic nephroma and its recurrence. Arch Pathol. 1973 Jul;96(1):66–70. [PubMed] [Google Scholar]
  9. Gonzalez-Crussi F., Sotelo-Avila C., Kidd J. M. Mesenchymal renal tumors in infancy: a reappraisal. Hum Pathol. 1981 Jan;12(1):78–85. doi: 10.1016/s0046-8177(81)80244-4. [DOI] [PubMed] [Google Scholar]
  10. Haas J. E., Bonadio J. F., Beckwith J. B. Clear cell sarcoma of the kidney with emphasis on ultrastructural studies. Cancer. 1984 Dec 15;54(12):2978–2987. doi: 10.1002/1097-0142(19841215)54:12<2978::aid-cncr2820541228>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  11. Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983 Nov;31(11):1333–1335. doi: 10.1177/31.11.6619538. [DOI] [PubMed] [Google Scholar]
  12. Howell C. G., Othersen H. B., Kiviat N. E., Norkool P., Beckwith J. B., D'Angio G. J. Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms' Tumor Study. J Pediatr Surg. 1982 Dec;17(6):826–831. doi: 10.1016/s0022-3468(82)80451-x. [DOI] [PubMed] [Google Scholar]
  13. Joshi V. V., Kasznica J., Walters T. R. Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma. Arch Pathol Lab Med. 1986 Feb;110(2):100–106. [PubMed] [Google Scholar]
  14. Joshi V. V., Kay S., Milsten R., Koontz W. W., McWilliams N. B. Congenital mesoblastic nephroma of infancy: report of a case with unusual clinical behavior. Am J Clin Pathol. 1973 Dec;60(6):811–816. doi: 10.1093/ajcp/60.6.811. [DOI] [PubMed] [Google Scholar]
  15. Knudson A. G., Jr, Strong L. C. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst. 1972 Feb;48(2):313–324. [PubMed] [Google Scholar]
  16. Kumar S., Carr T., Marsden H. B., Calabuig-Crespo M. C. Study of childhood renal tumours using antisera to fibronectin, laminin, and epithelial membrane antigen. J Clin Pathol. 1986 Jan;39(1):51–57. doi: 10.1136/jcp.39.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kumar S., Marsden H. B., Cowan R. A., Barnes J. M. Prognostic relevance of DNA content in childhood renal tumours. Br J Cancer. 1989 Feb;59(2):291–295. doi: 10.1038/bjc.1989.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Look A. T., Hayes F. A., Nitschke R., McWilliams N. B., Green A. A. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med. 1984 Jul 26;311(4):231–235. doi: 10.1056/NEJM198407263110405. [DOI] [PubMed] [Google Scholar]
  19. Marsden H. B., Newton W. A., Jr New look at mesoblastic nephroma. J Clin Pathol. 1986 May;39(5):508–513. doi: 10.1136/jcp.39.5.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Oppedal B. R., Storm-Mathisen I., Lie S. O., Brandtzaeg P. Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer. 1988 Aug 15;62(4):772–780. doi: 10.1002/1097-0142(19880815)62:4<772::aid-cncr2820620422>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  21. Pettinato G., Manivel J. C., Wick M. R., Dehner L. P. Classical and cellular (atypical) congenital mesoblastic nephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study. Hum Pathol. 1989 Jul;20(7):682–690. doi: 10.1016/0046-8177(89)90156-1. [DOI] [PubMed] [Google Scholar]
  22. Snyder H. M., 3rd, Lack E. E., Chetty-Baktavizian A., Bauer S. B., Colodny A. H., Retik A. B. Congenital mesoblastic nephroma: relationship to other renal tumors of infancy. J Urol. 1981 Oct;126(4):513–516. doi: 10.1016/s0022-5347(17)54601-7. [DOI] [PubMed] [Google Scholar]
  23. Steinfeld A. D., Crowley C. A., O'Shea P. A., Tefft M. Recurrent and metastatic mesoblastic nephroma in infancy. J Clin Oncol. 1984 Aug;2(8):956–960. doi: 10.1200/JCO.1984.2.8.956. [DOI] [PubMed] [Google Scholar]
  24. Tsurusawa M., Katano N., Kawai S., Fujimoto T., Maeda M. Prognostic implication of cellular DNA content in acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1988 Spring;10(1):75–80. doi: 10.1097/00043426-198821000-00013. [DOI] [PubMed] [Google Scholar]
  25. Walker D., Richard G. A. Fetal hamartoma of the kidney: recurrence and death of patient. J Urol. 1973 Sep;110(3):352–353. doi: 10.1016/s0022-5347(17)60214-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES